Danaher has been growing earnings at an average annual rate of 9.3%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 5.1% per year. Danaher's return on equity is 7.7%, and it has net margins of 16.6%.
Key information
9.3%
Earnings growth rate
8.6%
EPS growth rate
Life Sciences Industry Growth
20.2%
Revenue growth rate
5.1%
Return on equity
7.7%
Net Margin
16.6%
Last Earnings Update
27 Sep 2024
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Danaher makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
WBAG:DHRC Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
27 Sep 24
23,742
3,934
7,470
1,549
28 Jun 24
23,568
4,056
7,358
1,528
29 Mar 24
23,737
4,069
7,281
1,498
31 Dec 23
23,890
4,200
7,245
1,503
29 Sep 23
21,026
4,408
6,080
1,332
30 Jun 23
23,065
5,019
6,489
1,390
31 Mar 23
24,904
5,757
6,762
1,460
31 Dec 22
26,643
6,222
7,080
1,528
30 Sep 22
31,250
6,640
8,572
1,787
01 Jul 22
30,816
6,206
8,489
1,808
01 Apr 22
30,283
6,206
8,369
1,803
31 Dec 21
24,802
5,283
6,763
1,498
01 Oct 21
28,065
5,636
7,818
1,643
02 Jul 21
26,720
5,361
7,543
1,544
02 Apr 21
24,799
4,595
7,278
1,441
31 Dec 20
22,284
3,510
6,880
1,348
02 Oct 20
20,392
3,083
6,354
1,246
03 Jul 20
18,886
2,853
5,954
1,186
03 Apr 20
18,034
2,614
5,659
1,146
31 Dec 19
17,911
2,364
5,577
1,126
27 Sep 19
15,562
2,093
4,709
980
28 Jun 19
16,037
2,145
4,880
998
29 Mar 19
16,573
2,166
5,125
1,028
31 Dec 18
17,049
2,406
5,356
1,059
28 Sep 18
19,615
2,761
6,246
1,211
29 Jun 18
19,290
2,669
6,173
1,189
30 Mar 18
18,819
2,553
6,072
1,160
31 Dec 17
15,519
2,172
5,012
956
29 Sep 17
17,828
2,360
5,764
1,098
30 Jun 17
17,432
2,191
5,633
1,060
31 Mar 17
17,164
2,051
5,536
1,016
31 Dec 16
16,882
2,153
5,481
975
30 Sep 16
16,621
1,927
5,362
943
01 Jul 16
16,001
1,905
5,218
914
01 Apr 16
13,663
1,775
4,549
788
31 Dec 15
14,434
1,747
4,635
861
02 Oct 15
15,335
1,875
4,769
926
03 Jul 15
16,530
2,177
4,865
1,002
03 Apr 15
19,186
2,521
5,348
1,143
31 Dec 14
12,867
1,639
3,953
769
26 Sep 14
19,197
2,683
5,305
1,189
27 Jun 14
19,159
2,599
5,311
1,210
28 Mar 14
19,336
2,583
5,405
1,267
31 Dec 13
18,283
2,591
5,042
1,104
Quality Earnings: DHRC has high quality earnings.
Growing Profit Margin: DHRC's current net profit margins (16.6%) are lower than last year (21%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DHRC's earnings have grown by 9.3% per year over the past 5 years.
Accelerating Growth: DHRC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: DHRC had negative earnings growth (-11%) over the past year, making it difficult to compare to the Life Sciences industry average (-0.7%).
Return on Equity
High ROE: DHRC's Return on Equity (7.7%) is considered low.